Tag Archive | "HPV16"

BT Pharma secures EUR 13.1million (USD 17.7 million) in capital funding and changes its name to Genticel

Tuesday, March 9, 2010

0 Comments

Source: pharmalive.com/News Author: press release BT Pharma, a biopharmaceutical company developing innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today that it has raised EUR 13.1 million in additional funding and changed its name to Genticel. AGF Private Equity led the round, which brought in three new investors, IRDI (Institut Régional [...]

Continue reading...

Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma

Saturday, December 19, 2009

0 Comments

Source: Journal of Clinical Oncology, Vol 27, No 36 (December 20), 2009: pp. 6213-6221 Authors: Wei Shi et al. Purpose: A significant proportion of oropharyngeal squamous cell carcinomas (OSCC) are associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for HPV determination on archival materials however, remains unclear. We compared a quantitative [...]

Continue reading...

Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma

Thursday, November 5, 2009

0 Comments

Source: Journal of Clinical Oncology, 10.1200/JCO.2009.23.1670 Author: Wei Shi et al. Purpose: A significant proportion of oropharyngeal squamous cell carcinomas (OSCC) are associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for HPV determination on archival materials however, remains unclear. We compared a quantitative real-time polymerase chain reaction (qRT-PCR) assay for HPV16 [...]

Continue reading...

PMH finding may help some tonsil cancer patients avoid chemotherapy

Wednesday, November 4, 2009

0 Comments

Source: www.sciencecodex.com Author: staff Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer (“tonsil cancer”) harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the [...]

Continue reading...

HPV data may aid vaccine’s effectiveness

Monday, April 13, 2009

0 Comments

Source: health.usnews.com Author: staff The majority of invasive cervical cancers in New Mexico in the 1980s and 1990s contained DNA from human papillomavirus type 16 (HPV16) and HPV type 18 (HPV18), says a new study. It also found that women diagnosed with HPV16- or HPV18-positive cancers were an average of five years younger than those [...]

Continue reading...

HPV data may aid vaccine’s effectiveness

Friday, March 27, 2009

0 Comments

Source: health.usnews.com Author: staff The majority of invasive cervical cancers in New Mexico in the 1980s and 1990s contained DNA from human papillomavirus type 16 (HPV16) and HPV type 18 (HPV18), says a new study. It also found that women diagnosed with HPV16- or HPV18-positive cancers were an average of five years younger than those [...]

Continue reading...

Oral rinses used for tracking HPV-positive head and neck cancers hold promise for screening

Sunday, December 28, 2008

0 Comments

Source: American Association for Cancer Research Author: staff A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. In the study, researchers at Johns Hopkins University used oral rinses [...]

Continue reading...

Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening

Friday, October 31, 2008

0 Comments

Source: www.eurekalert.com Author: staff A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. In the study, researchers at Johns Hopkins University used oral rinses and targeted DNA amplification [...]

Continue reading...

Gardasil vaccine eradicating human papillomavirus infections

Thursday, July 24, 2008

0 Comments

Source: news.com.au Author: Kate Sikora The new cervical cancer vaccine is expected to almost eradicate human papillomavirus (HPV) infections in Australian women by 2050 if the high rate of immunization amongst girls continues. Research to be released today by the Cancer Council NSW reveals the number of new HPV cases in women will fall by [...]

Continue reading...